MFG-E8 expression in malignant melanoma and benign melanocytic nevi

被引:0
|
作者
Johnson, M. M.
Belsley, N. A.
Jinushi, M.
Carrasco, D. R.
Dranoff, G.
Mihm, M. C.
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
428
引用
收藏
页码:95A / 95A
页数:1
相关论文
共 50 条
  • [11] An Independent Validation of a Gene Expression Signature to Differentiate Malignant Melanoma From Benign Melanocytic Nevi
    Clarke, Loren E.
    Flake, Darl D., II
    Busam, Klaus
    Cockerell, Clay
    Helm, Klaus
    McNiff, Jennifer
    Reed, Jon
    Tschen, Jaime
    Kim, Jinah
    Barnhill, Raymond
    Elenitsas, Rosalie
    Prieto, Victor G.
    Nelson, Jonathan
    Kimbrell, Hillary
    Kolquist, Kathryn A.
    Brown, Krystal L.
    Warf, M. Bryan
    Roa, Benjamin B.
    Wenstrup, Richard J.
    CANCER, 2017, 123 (04) : 617 - 628
  • [12] Impact of E-Cadherin Expression Pattern in Melanocytic Nevi and Cutaneous Malignant Melanoma
    Seleit, Iman Abdel Fattah
    Samaka, Rehab Monir
    Basha, Mohammed Ahmed
    Bakry, Ola Ahmed
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2012, 34 (04): : 204 - 213
  • [13] IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS
    Chokoeva, A. A.
    Ananiev, J.
    Wollina, U.
    Tana, C.
    Lotti, T.
    Cardoso, J. C.
    Tchernev, G.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2015, 29 (03): : 695 - 699
  • [14] The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi
    Sand, Michael
    Skrygan, Marina
    Georgas, Dimitrios
    Sand, Daniel
    Gambichler, Thilo
    Altmeyer, Peter
    Bechara, Falk G.
    CELL AND TISSUE RESEARCH, 2012, 350 (01) : 119 - 126
  • [15] The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi
    Michael Sand
    Marina Skrygan
    Dimitrios Georgas
    Daniel Sand
    Thilo Gambichler
    Peter Altmeyer
    Falk G. Bechara
    Cell and Tissue Research, 2012, 350 : 119 - 126
  • [16] miRna Machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi
    Sand, M.
    Georgas, D.
    Kirschke, J.
    Skrygan, M.
    Gambichler, T.
    Altmeyer, P.
    Bechara, F. G.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (11): : 869 - 869
  • [17] MELANOCYTIC NEVI AND MALIGNANT-MELANOMA
    METCALF, JS
    MAIZE, JC
    DERMATOLOGIC CLINICS, 1985, 3 (02) : 217 - 224
  • [18] Expression of Melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma
    Busam, KJ
    Chen, YT
    Old, LJ
    Stockert, E
    Iversen, K
    Coplan, KA
    Rosai, J
    Barnhill, RL
    Jungbluth, AA
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (08) : 976 - 982
  • [19] Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi
    Sand, Michael
    Skrygan, Marina
    Sand, Daniel
    Georgas, Dimitrios
    Gambichler, Thilo
    Hahn, Stephan A.
    Altmeyer, Peter
    Bechara, Falk G.
    CELL AND TISSUE RESEARCH, 2013, 351 (01) : 85 - 98
  • [20] Development of a multiple gene RNA expression signature to differentiate malignant melanoma from benign melanocytic nevi
    Warf, M.
    Flake, D. D.
    Clarke, L. E.
    Gutin, A.
    Tahan, S. R.
    Kolquist, K. A.
    Rock, C.
    Shea, C. R.
    Berking, C.
    Roa, B. B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S31 - S31